AZZ Inc 第三季度财报超预期 - 公司第三季度调整后每股收益为1.52美元，超出市场预期的1.47美元 [1] - 公司销售额为4.25746亿美元，超出市场预期的4.18164亿美元 [1] - 受财报利好推动，公司股价在盘前交易中上涨2.1%至112.09美元 [1] 盘前交易中股价显著上涨的公司 - **CIMG Inc** 股价上涨33.3%至1.44美元，原因是公司获得了价值约1.24亿美元的计算能力相关商业合同 [4] - **ECD Automotive Design Inc** 股价上涨26.4%至0.59美元，因有贷款方正与公司洽谈价值200万至1000万美元的战略交易 [4] - **Acrivon Therapeutics Inc** 股价上涨22.1%至3.60美元，公司宣布将于1月8日提供其ACR-368药物2b期研究及计划中的3期确证性试验的临床更新、ACR-2316的初步临床数据以及其他AP3管线更新 [4] - **Nuvve Holding Corp** 股价上涨17.1%至4.11美元，此前在周三已上涨60% [4] - **RenovoRx Inc** 股价飙升16.8%至1.18美元 [4] - **Serina Therapeutics Inc** 股价上涨16.4%至2.82美元，此前在周三已上涨15% [4] - **Super League Enterprise Inc** 股价上涨11.2%至0.68美元，公司于1月5日与Let's Bounce签署了资产购买协议 [4] - **Regencell Bioscience Holdings Ltd** 股价上涨7.7%至56.87美元，此前在周三已上涨60% [4] - **Northrop Grumman Corp** 股价上涨6.8%至616.26美元，国防类公司股价普遍走高，可能与特朗普总统在社交媒体上表示希望将2027年军费预算从1万亿美元增至1.5万亿美元有关 [4] 盘前交易中股价显著下跌的公司 - **Immuneering Corp** 股价下跌20.7%至6.61美元，公司公布了其atebimetinib联合改良吉西他滨/白蛋白结合型紫杉醇一线治疗胰腺癌患者的2a期试验的最新总生存期和安全性数据，中位随访时间超过13个月 [4] - **Erasca Inc** 股价下跌14%至4.45美元，此前在周三上涨了42% [4] - **Phathom Pharmaceuticals Inc** 股价下跌13.7%至15.60美元，公司宣布了1.3亿美元普通股及预融资认股权证的公开发行定价 [4] - **Oriental Culture Holding Ltd** 股价下跌10.2%至0.021美元，此前在周三上涨超过5% [4] - **Australian Oilseeds Holdings Ltd** 股价下跌9.4%至0.71美元，此前在周三上涨了29% [4] - **Sky Quarry Inc** 股价下跌9.4%至0.62美元，此前在周三上涨了18% [4] - **FBS Global Ltd** 股价下跌9.3%至0.78美元，此前在周三下跌了5% [4] - **United Microelectronics Corp** 股价下跌6.3%至8.37美元，此前在周三因公司报告12月及全年销售额增长而上涨了10% [4] - **Cyclerion Therapeutics Inc** 股价下跌6.1%至1.69美元，此前在周三下跌了8% [4] - **Revolution Medicines Inc** 股价下跌6%至96.57美元，此前有报道称艾伯维未与公司进行谈判 [4]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

PresentationRegina GraulCEO, President & Director Good morning, everyone, and thank you for joining us today. I am Regina Graul, Chief Executive Officer of Cyclerion Therapeutics. I'm joined today by Dr. Husseini Manji, a globally recognized leader in neuroscience and mental health innovation. Dr. Manji's distinguished career spans leadership roles at the National Institute of Health, where he advanced foundational research on synaptic plasticity and at Janssen, Johnson & Johnson, where he served as Global ...

美股市场整体表现 - 美股早盘涨跌互现 纳斯达克综合指数上涨超过50点[1] - 道琼斯工业平均指数下跌0.03% 报48,962.01点 纳斯达克指数上涨0.31% 报23,469.03点 标普500指数上涨0.14% 报6,911.52点[1] 行业板块表现 - 能源股领涨 涨幅达2.9%[1] - 公用事业股表现落后 下跌2.2%[1] 公司业绩与事件 - AngioDynamics第二季度业绩超预期 调整后每股收益为0.00美元 超出市场预期的每股亏损0.10美元 销售额为7943.3万美元 超出预期的7630万美元[2] - Alumis Inc股价飙升148%至20.54美元 因其envudeucitinib治疗中重度斑块状银屑病的3期ONWARD1和ONWARD2试验顶线结果达到所有主要和次要终点[8] - Envirotech Vehicles股价大涨73%至0.6699美元 因公司宣布已签订经修订和重述的意向书 将通过合并交易收购AZIO AI 100%的已发行流通股权[8] - Cyclerion Therapeutics股价上涨54%至2.13美元 因公司宣布正扩大与Medsteer的战略合作 以推进闭环麻醉平台CYC-126[8] - Instil Bio股价暴跌53%至5.78美元 因其子公司Axion Bio终止了AXN-2510的临床开发 且Axion与ImmuneOnco Biopharmaceuticals已达成协议终止关于AXN-2510和AXN-27M的许可与合作协议[8] - MOBIX LABS股价下跌45%至0.18美元 因公司宣布其3000万股普通股的600万美元增发定价[8] - BitVentures Ltd – ADR股价下跌23%至11.40美元[8] 大宗商品市场 - 原油价格上涨0.5%至58.58美元[5] - 黄金价格上涨0.6%至4477.40美元[5] - 白银价格上涨2.4%至78.505美元[5] - 铜价上涨1.4%至6.0565美元[5] 全球其他市场 - 欧洲股市普遍上涨 欧元区STOXX 600指数上涨0.3% 西班牙IBEX 35指数上涨0.5% 英国富时100指数上涨1% 德国DAX指数上涨0.4% 法国CAC 40指数下跌0.3%[6] - 亚洲股市周二普遍收高 日本日经225指数上涨1.32% 香港恒生指数上涨1.38% 中国上证综合指数飙升1.50% 印度BSE Sensex指数下跌0.44%[7] 经济指标 - 物流经理人指数连续第二个月下降 12月为54.2 而前两个月均为55.7[9]

Shares of Cyclerion Therapeutics Inc (NASDAQ:CYCN) rose sharply in pre-market trading after the company announced it is expanding strategic collaboration with Medsteer to advance closed-loop anesthetic platform CYC-126.Cyclerion Therapeutics shares surged 44.2% to $1.99 in the pre-market trading session.Here are some other stocks moving in pre-market trading.GainersKandal M Venture Ltd (NASDAQ:FMFC) gained 40.9% to $0.47 in pre-market trading after rising 8% on Monday.Aeva Technologies Inc (NASDAQ:AEVA) ros ...

– Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer – – Comprehensive Business Update and Path to Initiating Phase 2 Proof-of-Concept (“POC”) Study in the Second Half of 2026 – – Webcast Being Held on January 6, 2026 at 8:00 a.m. ET, Featuring Key Opinion Leader, Dr. Husseini Manji – CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a biopharmaceutical company pioneering neuropsychiatric ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38787 Massachusetts (State or other jurisdiction of incorporation or organization) 245 First Street, 18 Floor, Cambridge, Ma ...

盘前交易概况 - 美东时间周四上午7:35盘前交易出现显著活跃 多只股票呈现价格异动[1] - 盘前价格变动可能预示开盘后潜在交易机会 包括突破、反转或剧烈波动[1] - 早盘动量通常延续至常规交易时段 使盘前分析成为交易日关键组成部分[1] 涨幅显著股票 - PepGen Inc (PEPG) 股价上涨151%至6.68美元 位列涨幅榜首[3] - 22nd Century Group Inc (XXII) 上涨27%至1.93美元 涨幅排名第二[3] - Immuneering Corporation (IMRX) 上涨23%至11.36美元 位列涨幅第三[3] - uniQure N.V. (QURE) 上涨10%至52.58美元 锂业公司Lithium Americas Corp (LAC)同步上涨9%至6.60美元[3] - Jasper Therapeutics Inc (JSPR) 上涨9%至2.55美元 American Shared Hospital Services (AMS) 上涨8%至2.75美元[3] - PSQ Holdings Inc (PSQH) 上涨7%至3.06美元 K Wave Media Ltd (KWM) 同步上涨7%至2.48美元[3] - ClearPoint Neuro Inc (CLPT) 上涨5%至20.48美元 跻身涨幅前十[3] 跌幅显著股票 - Transocean Ltd (RIG) 下跌14%至3.11美元 领跌盘前交易[4] - Cyclerion Therapeutics Inc (CYCN) 下跌12%至2.83美元 跌幅排名第二[4] - CarMax Inc (KMX) 下跌11%至50.38美元 ARB IOT Group Limited (ARBB) 同步下跌11%至10.45美元[4] - SHF Holdings Inc (SHFS) 下跌10%至6.49美元 Digital Brands Group Inc (DBGI) 同步下跌10%至6.21美元[4] - Aqua Metals Inc (AQMS) 下跌9%至5.29美元 Akanda Corp (AKAN) 下跌8%至3.96美元[4] - Galecto Inc (GLTO) 下跌8%至3.88美元 Platinum Analytics Cayman Limited (PLTS) 下跌7%至11.12美元[4]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

PresentationRegina GraulCEO, President & Director Good morning, everyone. Yesterday, we announced Cyclerion's transformational relaunch as a neuropsychiatric company, supported by an MIT licensing agreement that secures foundational intellectual property. A copy of this release and presentation to accompany this call are available on the Investor Relations section of our website at ir.cyclerion.com. I am Regina Graul, Chief Executive Officer of Cyclerion Therapeutics. Thank you for joining us for the Cycler ...